Fast start for Zika virus vaccines

BB Biotech boosts Intercell with EUR25M in equity and debt with royalty twist

Biotech 2Q12 buyside picks: Smaller caps, 1Q performers, European names

Europe's best-performing biotechs took on more risk, raised the most money

Intercell acquires ability to develop anti-infective mAbs in-house from Cytos